Day 1 of Momentum AI being live. Here's what we're hearing from early users: 'I finally feel in control of my information diet.' That's the whole mission. 🎯 Free plan available. Pro at $15/mo. #MomentumAI# #AI# #Productivity# #SaaS#

Momentum AI in one sentence: "It's like having a brilliant research assistant who reads ALL your newsletters and tells you only what matters." Free plan available. Pro at $15/mo. Team at $50/mo. We're live today. 🚀 #AI# #SaaS# #Productivity# #MomentumAI#

What if your newsletters could talk to each other? "Hey — 3 different sources mentioned this company today. Might be worth your attention." That's the intelligence built into Momentum AI. We're live. Join the waitlist. #AI# #Productivity# #FutureOfWork# #MomentumAI#

The average tech exec subscribes to 60+ newsletters. Reads maybe 5% of them. Meanwhile, their competitors are reading the ones they're missing. This is the information asymmetry problem nobody talks about. Momentum AI solves it. 👇 #AI# #Newsletter# #MomentumAI#

🚀 Momentum AI is LIVE. You subscribe to 47 newsletters. You read maybe 3. We fix that — one hyper-personalized morning briefing from ALL your subscriptions, ranked by what matters to YOU. Stop drowning in content. Start winning with it. #AI# #Productivity# #MomentumAI#

Momentum continues for the SKYWARD IDE clinical program with the first SKYWARD Transfemoral (TF) enrollment! ⚡ Huge congratulations to Dr. Peter Soukas and the team at The Miriam Hospital on enrolling the first transfemoral access patient in SKYWARD, the clinical program evaluating the novel Shockwave SkyRunner Carotid IVL System for the treatment of calcified carotid arteries prior to stenting. This milestone marks another important step forward as we continue to advance innovation in the treatment of calcified carotid disease. CAUTION - Investigational device. Limited by U.S. law to investigational use.